Molecular characterization of two host-guest associating hyaluronan derivatives

Biomedical Chromatography

Volumn 17, Issue 6, 2003, Pages 376-384

  Soltes L ^a   Mendichi, R ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b CNR   (Italy)

Author keywords

Host guest inclusion complexation; Hyaluronan derivatives; Light scattering; Polymacromolecular aggregation association; Size exclusion chromatography; Supramolecular biosystems

Indexed keywords

HYALURONIC ACID; LIGHT SCATTERING; SIZE EXCLUSION CHROMATOGRAPHY;

BIO-SYSTEMS; EQUIMOLAR MIXTURES; HOST-GUEST/INCLUSION COMPLEXATION; HOST:GUEST; HYALURONAN; HYALURONAN DERIVATIVE; INCLUSION COMPLEXATION; POLYMACROMOLECULAR AGGREGATION/ASSOCIATION; SIZE-EXCLUSION CHROMATOGRAPHY; SUPRAMOLECULAR BIOSYSTEM;

MOLECULAR WEIGHT;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; BETA CYCLODEXTRIN; HYALURONIC ACID DERIVATIVE; WATER;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; DATA ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; LIGHT SCATTERING; MACROMOLECULE; MOLECULAR WEIGHT; ONLINE SYSTEM; POLYMERIZATION; SOLUBILITY;

EID: 0141478817     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.252     Document Type: Article

References (27)

1. Amiel C and Sébille B. New associating polymer systems involving water-soluble β cyclodextrin polymers. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry 1996; 25: 61-67.
2. Balázs EA, Watson D, Duff IF and Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis and Rheumatism 1967: 10: 357-376.
3. Balázs EA, Laurent TC and Jeanloz RW. Nomenclature of hyaluronic-acid. Biochemical Journal 1986; 235: 903-903.
4. Burger K, Illés J, Gyurcsik B, Gazdag M, Forrai E, Dékány I and Mihályfi K. Metal ion coordination of macromolecular bioligands: formation of zinc(II) complex of hyaluronic acid. Carbohydrate Research 2001: 332: 197-207.
5. Bystrický S, Alföldi J, Machová E, Steiner B and Šoltés L. Nonbiodegradable hyaluronan derivative prepared by reaction with a water soluble carbodiimide. Chemické Zvesti (Chemical Papers) 2001; 55: 49-52.
6. Chabreček P, Šoltés L, Kállay Z and Guttmann M. Method of preparation of conjugates of hyaluronic acid or its salts with biologically active substances. Slovak patent no. 2761; Priority Date: July 2, 1990.
7. Cleland RL. Ionic polysaccharides. II. Comparison of polyelectrolyte behavior of hyaluronate with that of carboxymethyl cellulose. Biopolymers 1968; 6: 1519-1529.
8. Cromwell WC, Byström K and Eftink MR. Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity size. Journal of Physical Chemistry 1985; 89: 326-332.
9. Ghosh S, Kobal I, Zanette D and Reeds WF. Conformational contraction and hydrolysis of hyaluronate in sodium-hydroxide solutions. Macromolecules 1993; 26: 4685-4693.
10. Gibbs DA, Merrill EW, Smith KA and Balázs EA. Rheology of hyaluronic acid. Biopolymers 1968; 6: 777-791.
11. Hoare DG and Koshland DE Jr. A method for the quantitative modification and estimation of carboxylic acid groups in proteins, Journal of Biological Chemistry 1967; 242: 2447-2453.
12. Kikuchi T, Yamada H and Shimmei M. Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis and Cartilage 1996; 4: 99-110.
13. 2+ ions. Macromolecular Chemistry and Physics 1999; 200: 2003-2014.
14. Mendichi R and Giacometti Schieroni A. Fractionation and characterization of ultra-high molar mass hyaluronan: 2. On-line size exclusion chromatography methods. Polymer 2002; 43: 6115-6121.
15. Meyer K and Palmer JW. The polysaccharide of the vitreous humor. Journal of Biological Chemistry 1934; 107: 629-634.
16. Mitsunobu O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis-Stuttgart 1981; 1: 1-28.
17. 14C]-hyaluronic acid or its salts with a defined molecular weight and a specific radioactivity. Slovak Patent no. 280150; Priority Date: December 27, 1990.
18. Oviatt HW Jr and Brant DA. Thermal treatment of semi-dilute aqueous xanthan solutions yields weak gels with properties resembling hyaluronic acid. International Journal of Biological Macromolecules 1993; 15: 3-10.
19. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. Journal of Rheumatology 1993; 20, suppl. 39: 10-15.
20. Rekharsky MV and Inoue Y. Complexation thermodynamics of cyclodextrins. Chemical Reviews 1998: 98: 1875-1917.
21. 4OH solution. Carbohydrate Polymers 2000; 41: 9-14.
22. Šoltés L, Mislovičová D and Sebille B. Insight into the distribution of molecular weights and higher-order structure of hyaluronans and some β-(1→3)-glucans by size exclusion chromatography. Biomedical Chromatography 1996; 10: 53-59.
23. Šoltés L, Mendichi R, Machová E, Steiner B, Alföldi J, Sasinková V, Bystrický S and Balog K. Cyclodextrin derivative of hyaluronan. Carbohydrate Polymers 1999; 39: 17-24.
24. Šoltés L, Bystrický S, Steiner B, Machová E, Mendichci R, Bauer V, Kogan G, Alföldi J, Stratilová E and Mach M. Method of preparation of ultra-high molecular-weight hyaluronans. Slovak Patent no. 282717; Priority Date: March 10, 2000.
25. Šoltés L, Bystrický S, Steiner B, Machová E, Mendichi R, Bauer V, Kogan G, Alföldi J, Stratilová E and Mach M. Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals. Patent pending PCT WO 01/66601 Al; Priority Date: March 12, 2001.
26. Šoltés L, Mendichi R, Lath D, Mach M and Bakoš D. Molecular characteristics of some commercial high-molecular-weight hyaluronans. Biomedical Chromatography 2002; 16: 459-462.
27. Szejtli J. Cyclodextrins and their Inclusion Complexes. Akadémiai Kiadó, Budapest, 1982.